Investor Expectations to Drive Momentum within VWR, The Michaels Companies, KalVista Pharmaceuticals, PACCAR, Jaguar Health, and CPI Card Group – Discovering Underlying Factors of Influence

Investor Expectations to Drive Momentum within VWR, The Michaels Companies, KalVista Pharmaceuticals, PACCAR, Jaguar Health, and CPI Card Group – Discovering Underlying Factors of Influence

NEW YORK, Nov. 01, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of VWR Corporation (NASDAQ:VWR), The Michaels Companies, Inc. (NASDAQ:MIK), KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), PACCAR Inc (NASDAQ:PCAR), Jaguar Health, Inc. (NASDAQ:JAGX), and CPI Card Group Inc. (NASDAQ:PMTS) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

VWR DOWNLOAD: http://Fundamental-Markets.com/register/?so=VWR

MIK DOWNLOAD: http://Fundamental-Markets.com/register/?so=MIK

KALV DOWNLOAD: http://Fundamental-Markets.com/register/?so=KALV

PCAR DOWNLOAD: http://Fundamental-Markets.com/register/?so=PCAR

JAGX DOWNLOAD: http://Fundamental-Markets.com/register/?so=JAGX

PMTS DOWNLOAD: http://Fundamental-Markets.com/register/?so=PMTS

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  VWR Corporation (NASDAQ:VWR), The Michaels Companies, Inc. (NASDAQ:MIK), KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), PACCAR Inc (NASDAQ:PCAR), Jaguar Health, Inc. (NASDAQ:JAGX), and CPI Card Group Inc. (NASDAQ:PMTS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed October 31, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

VWR CORPORATION (VWR) REPORT OVERVIEW

VWR's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, VWR reported sales of $1,175.3 vs $1,149.5 (up 2.1%), diluted earnings per share $0.28 vs $0.32 (down 12.5%). For the twelve months ended December 31, 2016 vs December 31, 2015, VWR reported revenue of $4,514.2 vs $4,318.8 (up 4.5%), diluted earnings per share $1.12 vs $1.17 (down 4.3%). VWR is expected to report earnings on 11/07/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $0.46. The reported EPS for the same quarter last year was $0.44.

To read the full VWR Corporation (VWR) report, download it here: http://Fundamental-Markets.com/register/?so=VWR

-----------------------------------------

THE MICHAELS COMPANIES, INC. (MIK) REPORT OVERVIEW

Michaels Companies' Recent Financial Performance

For the three months ended July 29, 2017 vs July 30, 2016, Michaels Companies reported revenue of $1,072.59 vs $1,060.35 (up 1.2%), diluted earnings per share $0.19 vs $0.17 (up 11.8%). For the twelve months ended January 28, 2017 vs January 28, 2016, Michaels Companies reported revenue of $5,197.29 vs $4,912.78 (up 5.8%), diluted earnings per share $1.82 vs $1.72 (up 5.8%). Michaels Companies is expected to report earnings on 12/05/2017. The report will be for the fiscal Quarter ending October 2017. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $0.42. The reported EPS for the same quarter last year was $0.40.

To read the full The Michaels Companies, Inc. (MIK) report, download it here: http://Fundamental-Markets.com/register/?so=MIK

-----------------------------------------

KALVISTA PHARMACEUTICALS, INC. (KALV) REPORT OVERVIEW

KalVista Pharmaceuticals' Recent Financial Performance

For the three months ended July 31, 2017 vs July 31, 2016, KalVista Pharmaceuticals reported net loss of -$4.93 vs $0.89, diluted earnings per share -$0.51 vs -$6.66. For the twelve months ended April 30, 2017 vs April 30, 2016, KalVista Pharmaceuticals reported net loss of -$18.60 vs -$11.44, diluted earnings per share -$4.47 vs -$26.17.

To read the full KalVista Pharmaceuticals, Inc. (KALV) report, download it here: http://Fundamental-Markets.com/register/?so=KALV

-----------------------------------------

PACCAR INC (PCAR) REPORT OVERVIEW

PACCAR's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, PACCAR reported revenue of $4,397.9 vs $4,115.8 (up 6.9%), diluted earnings per share $1.06 vs $1.37 (down 22.6%), and dividends per share $0.25 vs $0.24 (up 4.2%). For the twelve months ended December 31, 2016 vs December 31, 2015, PACCAR reported revenue of $17,033.3 vs $19,115.1 (down 10.9%), diluted earnings per share $1.48 vs $4.51 (down 67.2%), and dividends per share $1.56 vs $2.32 (down 32.8%).

To read the full PACCAR Inc (PCAR) report, download it here: http://Fundamental-Markets.com/register/?so=PCAR

-----------------------------------------

JAGUAR HEALTH, INC. (JAGX) REPORT OVERVIEW

Jaguar Health's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Jaguar Health reported revenue of $0.90 vs $0.02 (up 4400.0%), diluted earnings per share -$0.12 vs -$0.35. For the twelve months ended December 31, 2016 vs December 31, 2015, Jaguar Health reported revenue of $0.14 vs $0.26 (down 46.2%), diluted earnings per share -$1.35 vs -$2.70. Jaguar Health is expected to report earnings on 11/13/2017. According to Zacks Investment Research, based on 1 analysts forecasts, the consensus EPS forecast for the quarter is -$0.13. The reported EPS for the same quarter last year was -$0.30.

To read the full Jaguar Health, Inc. (JAGX) report, download it here: http://Fundamental-Markets.com/register/?so=JAGX

-----------------------------------------

CPI CARD GROUP INC. (PMTS) REPORT OVERVIEW

CPI Card Group's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, CPI Card Group reported revenue of $65.8 vs $73.7 (down 10.7%), diluted earnings per share -$0.04 vs -$0.01. For the twelve months ended December 31, 2016 vs December 31, 2015, CPI Card Group reported revenue of $308.7 vs $374.1 (down 17.5%), diluted earnings per share $0.10 vs -$0.04. CPI Card Group is expected to report earnings on 11/07/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $0.03. The reported EPS for the same quarter last year was $0.10.

To read the full CPI Card Group Inc. (PMTS) report, download it here: http://Fundamental-Markets.com/register/?so=PMTS

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.